Table 1.
Histologic parameter | Endometrioid endometrial carcinoma | Non-endometrioid endometrial carcinoma | p* |
---|---|---|---|
Tumour differentiation | < 0.001 | ||
G1 | 125 (59.2%) | 2 (13.3%) | |
G2 | 63 (29.9%) | 4 (26.6%) | |
G3 | 23 (10.9%) | 9 (60.0%) | |
Myometrial invasion | |||
none | 8 (3.8%) | 1 (6.3%) | 0.888 |
less than ½ | 123 (58.3%) | 9 (56.2%) | |
more than ½ | 80 (37.9%) | 6 (37.5%) | |
2009 FIGO stage | |||
IA | 114 (54.0%) | 7 (43.8%) | 0.025 |
IB | 54 (25.6%) | 1 (6.3%) | |
II | 14 (6.6%) | 2 (12.5%) | |
IIIA | 7 (3.3%) | 1 (6.3%) | |
IIIB | 5 (2.4%) | 0 (0.0%) | |
IIIC1 | 11 (4.7%) | 2 (12.5%) | |
IIIC2 | 0 (0.0%) | 0 (0.0%) | |
IVA | 1 (0.5%) | 1 (6.3%) | |
IVB | 5 (2.4%) | 2 (12.5%) |
chi-square test